EnBio Holdings, Inc (6092.T)
JPY 580.0
(-1.02%)
JPY 580.0
(-1.02%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 1.66 Billion | 1.98 Billion | 2.41 Billion | 297.15 Million | 951 Million |
| Net Income | 1.06 Billion | 1.23 Billion | 1.09 Billion | 488.31 Million | 555 Million |
| Depreciation & Amortization | 438.52 Million | 400.24 Million | 341.87 Million | 367.18 Million | 426 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 813.65 Million | 794.96 Million | 1.33 Billion | -547.71 Million | 370 Million |
| Other non-cash items | -75.45 Million | 128.22 Million | -181.93 Million | 461.73 Million | -400 Million |
| Investing Cash Flow | -1.58 Billion | -1.77 Billion | -1.48 Billion | -2.15 Billion | 3.86 Billion |
| Investments in PPE | -1.07 Billion | -1.16 Billion | -1.16 Billion | -1.73 Billion | -357 Million |
| Acquisitions | -193.87 Million | - | 5 Million | 14.4 Million | 4.37 Billion |
| Investment purchases | -1.88 Million | -23.68 Million | -119.41 Million | -1.67 Million | -349.46 Million |
| Sales/Maturities of investments | 7.2 Million | 7.66 Million | 35.37 Million | - | 130 Million |
| Other Investing Activities | -35.97 Million | -36.99 Million | -138.31 Million | -1.59 Million | 4.22 Billion |
| Financing Cash Flow | 638.92 Million | 240.72 Million | -534.92 Million | 928.53 Million | -4.06 Billion |
| Debt repayment | -313.26 Million | -315.84 Million | -454.12 Million | -912.48 Million | -3.67 Billion |
| Dividends payments | -52.96 Million | -52.89 Million | - | - | - |
| Common Stock Repurchased | - | - | -43.87 Million | - | - |
| Common Stock Issuance | 1.05 Billion | - | 5.65 Million | 16.05 Million | 1 Million |
| Other Financing Activities | -50.84 Million | -22.22 Million | -42.57 Million | -522 Million | -166.98 Million |
| Accounts receivables | -471 Million | 802 Million | -640 Million | 377 Million | 55 Million |
| Accounts payables | 537.13 Million | -220.22 Million | 153.92 Million | -163.55 Million | -87.65 Million |
| Inventory | 787.3 Million | 155.92 Million | 1.49 Billion | -662.24 Million | 74 Million |
| Other working capital | -370 Million | 34 Million | -32 Million | 230 Million | 241 Million |
| Cash at beginning of period | 2.79 Billion | 2.34 Billion | 1.98 Billion | 2.95 Billion | 2.18 Billion |
| Cash at end of period | 3.57 Billion | 2.79 Billion | 2.34 Billion | 1.98 Billion | 769 Million |
| Capital Expenditure | -1.07 Billion | -1.16 Billion | -1.16 Billion | -1.73 Billion | -357 Million |
| Effect of forex changes on cash | 7.82 Million | -2.36 Million | -40.5 Million | -31.91 Million | 11 Million |
| Net cash flow / Change in cash | 775.42 Million | 457.01 Million | 356.32 Million | -965.73 Million | -1.41 Billion |
| Free Cash Flow | 584.35 Million | 824.13 Million | 1.24 Billion | -1.43 Billion | 594 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 351 Million | 1.06 Billion | 363 Million | 24 Million | 151 Million | 170 Million |
| Depreciation & Amortization | - | 438.52 Million | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 813.65 Million | - | - | - | - |
| Other non-cash items | -351 Million | -75.45 Million | -363 Million | -24 Million | -151 Million | -170 Million |
| Investing Cash Flow | - | -1.58 Billion | - | - | - | - |
| Investments in PPE | - | -1.07 Billion | - | - | - | - |
| Acquisitions | - | -193.87 Million | - | - | - | - |
| Investment purchases | - | -1.88 Million | - | - | - | - |
| Sales/Maturities of investments | - | 7.2 Million | - | - | - | - |
| Other Investing Activities | - | -35.97 Million | - | - | - | - |
| Financing Cash Flow | - | 638.92 Million | - | - | - | - |
| Debt repayment | - | -313.26 Million | - | - | - | - |
| Dividends payments | - | -52.96 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 1.05 Billion | - | - | - | - |
| Other Financing Activities | - | -50.84 Million | - | - | - | - |
| Accounts receivables | - | -471 Million | - | - | - | - |
| Accounts payables | - | 537.13 Million | - | - | - | - |
| Inventory | - | 787.3 Million | - | - | - | - |
| Other working capital | - | -370 Million | - | - | - | - |
| Cash at beginning of period | - | 2.79 Billion | - | - | - | - |
| Cash at end of period | - | 3.57 Billion | - | - | - | - |
| Capital Expenditure | - | -1.07 Billion | - | - | - | - |
| Effect of forex changes on cash | - | 7.82 Million | - | - | - | - |
| Net cash flow / Change in cash | - | 775.42 Million | - | - | - | - |
| Free Cash Flow | - | 584.35 Million | - | - | - | - |
CRW
0315
6039
CEBCF
RAYT
1781